Inventor
ERB KLAUS
DE15 patents
⚠️ This page may combine multiple inventors who share the name “ERB KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
6 patentsUS7517995B2Apr 14, 2009
Thiazolyl-dihydro-cyclopentapyrazole
BOEHRINGER INGELHEIM INT10 citations83
US7691868B2Apr 6, 2010
Thiazolyl-dihydro-quinazoline
BOEHRINGER INGELHEIM INT3 citations61
US12171795B2Dec 24, 2024
Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein
BOEHRINGER INGELHEIM INT0 citations58
US12453749B2Oct 28, 2025
Recombinant rhabdovirus encoding for CCL21
BOEHRINGER INGELHEIM INT0 citations56
US11707495B2Jul 25, 2023
Recombinant rhabdovirus encoding for CCL21
BOEHRINGER INGELHEIM INT0 citations56
US8354418B2Jan 15, 2013
Thiazolyl-dihydro-quinazolines
BOEHRINGER INGELHEIM INT0 citations40
ABLYNX NV
5 patentsUS11208476B2Dec 28, 2021
Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV12 citations83
US11840566B2Dec 12, 2023
Methods of treating asthma with polypeptides targeting IL-13 and TSLP
ABLYNX NV1 citations70
US12492248B2Dec 9, 2025
Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV0 citations59
US12384840B2Aug 12, 2025
Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV0 citations59
US12509522B2Dec 30, 2025
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L
ABLYNX NV0 citations47